人民网北京12月16日电 （记者乔业琼）据厦门疾控微信公众号消息，免疫是人体与生俱来的健康 盾牌，而疫苗则是为这面盾牌特别锻造的"强化装备"。 那些疫苗"超能力" 天花疫苗：人类唯一彻底消灭的传染病，疫苗立下头功 脊髓灰质炎疫苗：让"小儿麻痹症"成为历史名词 HPV疫苗：目前唯一种能预防癌症的疫苗 疫苗的魔法：如何教会身体"记住"敌人？ 身体的免疫系统就像一支精锐部队，而疫苗的作用，就是给这支部队： 送上"敌人画像"（灭活/减毒疫苗） 展示"敌人武器模型"（重组蛋白疫苗） 提供"敌人作战手册"（mRNA疫苗） 通过这种方式，免疫系统在不经历真实感染风险的情况下，提前认识了敌人，并形成了长期"记 忆"。当真正的病原体入侵时，记忆免疫细胞便会迅速识别并消灭它们——这个过程甚至可能快到你感 觉不到自己曾被感染。 三是"群体免疫"是什么？ 关于疫苗的"灵魂三问" 一是为什么打了疫苗还会生病？ 疫苗不是"金钟罩"，而更像是"防弹衣"。它能显著降低重症和死亡风险，就像戴了头盔虽然可能还 会受伤，但能保住性命。 二是疫苗副作用可怕吗？ 常见的局部红肿、低热，其实是免疫系统正在"认真学习"的表现。严重不良反应的发生率，比许多 ...

Core Insights - The pharmaceutical and health industry is a key driver of innovation and development in Beijing, with the city expected to become the first in China to surpass a trillion yuan in this sector by 2024 [1] - Yizhuang Guotou is focusing on building an innovative ecosystem in the pharmaceutical and health sector, leveraging state-owned capital to stabilize investments and enhance industrial layout [2] Investment Strategy - Despite facing pressures from global economic fluctuations and the pandemic, Yizhuang Guotou is actively investing in the pharmaceutical sector, committing nearly 1 billion yuan in 2024 across 20 projects, with a focus on innovative drug development and high-end medical devices [2][4] - The company aims for a "dual-core + multi-track" investment strategy, covering various sub-sectors such as gene therapy and AI in healthcare, with early-stage projects making up 70% of its investments [4] Ecosystem Development - Yizhuang Guotou is building a comprehensive service system for portfolio companies, providing strategic planning, market expansion, and compliance support to enhance their core value [5] - The company is fostering collaboration with various funds and market players to create an investment ecosystem, successfully attracting over 10 quality enterprises to the Beijing Economic-Technological Development Area [6] Performance Metrics - In 2024, Yizhuang Guotou achieved a record high with 76 investment project decisions and over 30 billion yuan in funding across 64 projects, supporting high-tech initiatives [7] - The company plans to maintain a robust investment budget exceeding 10 billion yuan in 2025 to continue driving innovation and capital flow in the region [7]